Chinese enterprises seem to bringing a massive technological advancement to the Japanese market with high-tech and business model innovation. According to the data from the Ministry of Commerce in April 2019, the bilateral trade between the two countries, China and Japan has reached $327.66 billion in 2018 and direct investments made by China in all industries was known to be $251 million in 2018, which has known to grow from the year before. These investments have helped Japan compensate for a shortage of labour faced by the ageing population in Japan.
“Japan is facing a serious ageing problem. The population is shrinking and each region has its own problems,” said Takeo Donoue, Director General for the Beijing Office of JETRO, ”Young Chinese companies in particular have a lot of technologies related to AI and big data. If they can use these new technologies and ideas to help Japan solve real problems, it will be an extremely promising result.”
Infervision Technology Corp is one of the first AI products based Chinese companies in Japan that is based on doing clinical trial samples for radiologists to read x-rays and identify possible lesions. The company has made significant difference to the radiologists in Japan as 80% of them are liberated and have also received attention from varying Japanese medical industry and media. “AI products cannot replace doctors, but they can be assistants,” Zhou Xiaoyan, Infervision’s President says, “In the future, the products will be updated and iterated constantly to better integrate into the medical process, based on the feedback from Japanese doctors.”